Matched unrelated human umbilical cord blood transplantation for X-linked adrenoleukodystrophy

J Pediatr Hematol Oncol. 1998 May-Jun;20(3):257-9. doi: 10.1097/00043426-199805000-00013.

Abstract

Purpose: This report evaluates engraftment, immunologic reconstitution, and sera very-long-chain fatty acid levels after matched unrelated human umbilical cord blood transplantation (HUCBT) for adrenoleukodystrophy (ALD).

Patient and methods: A child with X-linked ALD underwent matched unrelated HUCBT and administration of granulocyte colony stimulating factor in combination with erythropoietin.

Results: Engraftment was complete and stable, with 100% chimerism. Natural killer cell numbers and function were normal more than 3 months after HUCBT. T cell numbers normalized more than 9 months after HUCBT but T cell mitogenic response remained subnormal. Thirteen months after transplantation, the child is in very good clinical condition with normalization of his sera very-long-chain fatty acid levels.

Conclusion: Unrelated cord blood transplantation may provide a good source of stem cells for patients with ALD when a matched sibling is not available.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenoleukodystrophy / blood
  • Adrenoleukodystrophy / therapy*
  • Blood Transfusion*
  • Child
  • Combined Modality Therapy
  • Erythropoietin / administration & dosage
  • Fatty Acids / blood
  • Fetal Blood*
  • Granulocyte Colony-Stimulating Factor / administration & dosage
  • Humans
  • Male

Substances

  • Fatty Acids
  • Erythropoietin
  • Granulocyte Colony-Stimulating Factor